var data={"title":"Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Causes, clinical manifestations, evaluation, and diagnosis of nonspecific interstitial pneumonia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/contributors\" class=\"contributor contributor_credentials\">Kevin R Flaherty, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/contributors\" class=\"contributor contributor_credentials\">Talmadge E King, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/contributors\" class=\"contributor contributor_credentials\">Helen Hollingsworth, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 18, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H574550203\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonspecific interstitial pneumonia (NSIP) is one type of idiopathic interstitial pneumonia (IIP). The other IIPs include usual interstitial pneumonia <span class=\"nowrap\">(UIP)/idiopathic</span> pulmonary fibrosis (IPF), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), acute interstitial pneumonia (AIP), lymphocytic interstitial pneumonia (LIP), and cryptogenic organizing pneumonia (COP) (<a href=\"image.htm?imageKey=PULM%2F95445\" class=\"graphic graphic_table graphicRef95445 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/1\" class=\"abstract_t\">1</a>].</p><p>NSIP can be idiopathic or can be seen in association with HIV infection, connective tissue diseases, a variety of drugs, and hypersensitivity pneumonitis. It can also present in combination with the other IIPs.</p><p>The etiology, pathogenesis, clinical manifestations, and diagnosis of NSIP will be reviewed here. The treatment and prognosis of NSIP, and the pathology, clinical manifestations, diagnosis, and treatment of the other IIPs are discussed separately. (See <a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">&quot;Idiopathic interstitial pneumonias: Clinical manifestations and pathology&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis&quot;</a> and <a href=\"topic.htm?path=treatment-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">&quot;Treatment of idiopathic pulmonary fibrosis&quot;</a> and <a href=\"topic.htm?path=respiratory-bronchiolitis-associated-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Respiratory bronchiolitis-associated interstitial lung disease&quot;</a> and <a href=\"topic.htm?path=cryptogenic-organizing-pneumonia\" class=\"medical medical_review\">&quot;Cryptogenic organizing pneumonia&quot;</a> and <a href=\"topic.htm?path=acute-interstitial-pneumonia-hamman-rich-syndrome\" class=\"medical medical_review\">&quot;Acute interstitial pneumonia (Hamman-Rich syndrome)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H376211228\"><span class=\"h1\">DEFINITION AND CAUSES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP is a chronic interstitial pneumonia that is characterized by a homogeneous appearance of dense or loose interstitial fibrosis with mild to moderate chronic interstitial inflammation (<a href=\"image.htm?imageKey=PULM%2F81034\" class=\"graphic graphic_table graphicRef81034 \">table 2</a>). </p><p>It is &quot;nonspecific&quot; in that it lacks the histopathologic features that characterize usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), respiratory bronchiolitis-associated interstitial lung disease (RB-ILD), or acute interstitial pneumonia (AIP), such as fibroblast foci, dense alveolar septal fibrosis, organizing pneumonia, granulomas, conspicuous infiltration of lymphocytes or eosinophils, and temporal heterogeneity. </p><p>NSIP can be idiopathic; it has also been associated with many medical conditions, although the specific causal link has not been identified. </p><p class=\"headingAnchor\" id=\"H445277849\"><span class=\"h2\">HIV infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP is less frequently identified in patients with HIV-infection since the widespread use of antiretroviral therapy (ART), but still occurs [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/2,3\" class=\"abstract_t\">2,3</a>]. In one observational study of 110 patients with AIDS and interstitial lung disease, NSIP was detected in 38 percent [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/4\" class=\"abstract_t\">4</a>]. A study performed since the introduction of ART found that 7 percent of HIV patients admitted with ILD had NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/5\" class=\"abstract_t\">5</a>]. Nearly half of these patients had normal chest radiographs. </p><p class=\"headingAnchor\" id=\"H1892991025\"><span class=\"h2\">Connective tissue disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP is a common pattern in patients with interstitial lung disease (ILD) that arises in the context of connective tissue disease (CTD, also referred to as systemic rheumatic disease), including polymyositis-dermatomyositis, rheumatoid arthritis, Sj&ouml;gren syndrome, and systemic sclerosis (scleroderma) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/6-15\" class=\"abstract_t\">6-15</a>]. Of note, the exact ILD histopathology is not always known in patients with CTD, as a lung biopsy is not always obtained. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In an observational study of 70 patients with polymyositis-dermatomyositis (PD) and ILD, the most common pulmonary presentation was presumed acute or subacute antibiotic resistant community acquired pneumonia [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/9\" class=\"abstract_t\">9</a>]. NSIP was identified in 18 of 22 patients who underwent lung biopsy. (See <a href=\"topic.htm?path=interstitial-lung-disease-in-dermatomyositis-and-polymyositis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Among 16 patients with rheumatoid arthritis and ILD, seven had features most consistent with NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/14\" class=\"abstract_t\">14</a>]. (See <a href=\"topic.htm?path=interstitial-lung-disease-in-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Interstitial lung disease in rheumatoid arthritis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Of nine patients with Sj&ouml;gren's syndrome and ILD, three had NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/13\" class=\"abstract_t\">13</a>]. (See <a href=\"topic.htm?path=interstitial-lung-disease-associated-with-sjogren-syndrome-clinical-manifestations-evaluation-and-diagnosis\" class=\"medical medical_review\">&quot;Interstitial lung disease associated with Sj&ouml;gren syndrome: Clinical manifestations, evaluation, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In 80 patients with ILD associated with systemic sclerosis, NSIP was identified in 62 (78 percent) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/11\" class=\"abstract_t\">11</a>]. In another study of patients with systemic sclerosis, 13 of 19 had NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/12\" class=\"abstract_t\">12</a>]. (See <a href=\"topic.htm?path=overview-of-pulmonary-complications-of-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">&quot;Overview of pulmonary complications of systemic sclerosis (scleroderma)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic sclerosis sine scleroderma (a rare illness characterized by the typical vascular features and visceral fibrosis of systemic sclerosis but without skin sclerosis) can present with dyspnea with radiographic features of NSIP or UIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/16\" class=\"abstract_t\">16</a>]. Patients usually have subtle physical exam findings such as scattered telangiectasia, Raynaud's phenomenon, esophageal reflux, pericardial effusion, and abnormal nailfold capillaroscopy. Antinuclear antibodies are typically of the nucleolar pattern. (See <a href=\"topic.htm?path=overview-and-classification-of-scleroderma-disorders#H7\" class=\"medical medical_review\">&quot;Overview and classification of scleroderma disorders&quot;, section on 'SSc sine scleroderma'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>NSIP is described in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (often microscopic polyangiitis), although a pattern of usual interstitial pneumonia is more common [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/17\" class=\"abstract_t\">17</a>]. (See <a href=\"topic.htm?path=respiratory-tract-involvement-in-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis#H1761910734\" class=\"medical medical_review\">&quot;Respiratory tract involvement in granulomatosis with polyangiitis and microscopic polyangiitis&quot;, section on 'Interstitial lung disease'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H718396560\"><span class=\"h2\">Interstitial pneumonia with autoimmune features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some patients with idiopathic interstitial pneumonia on lung biopsy (eg, NSIP, <span class=\"nowrap\">UIP/IPF)</span> have features of autoimmune disease, but the findings are insufficient for definitive diagnosis of a specific CTD [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/15,18,19\" class=\"abstract_t\">15,18,19</a>]. A multidisciplinary task force has proposed criteria for this entity, under the name &quot;interstitial pneumonia with autoimmune features (IPAF)&quot; [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/19\" class=\"abstract_t\">19</a>]. IPAF is not considered a diagnosis, but a way of unifying patients with these characteristics for clinical research. Several terms had previously been used to describe these patients, including undifferentiated CTD-ILD, lung-dominant CTD, and autoimmune-featured ILD. The preference for the term &quot;autoimmune features&quot; over &quot;undifferentiated CTD&quot; is that the latter has the connotation of a defined disease, while &quot;autoimmune features&quot; describes the possibility of an underlying autoimmune process centered on the lung.</p><p>Proposed criteria for IPAF are organized around three domains: a clinical domain composed of extrapulmonary clinical features, a serologic domain of specific autoantibodies, and a morphologic domain that includes pulmonary physiologic, chest imaging, and histopathologic features (<a href=\"image.htm?imageKey=PULM%2F114388\" class=\"graphic graphic_table graphicRef114388 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/19\" class=\"abstract_t\">19</a>]. To meet criteria for IPAF, a patient must manifest at least one feature from at least two domains.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clinical features</strong> &ndash; Distal digital fissuring or tip ulceration, unexplained digital edema, inflammatory arthritis or polyarticular morning stiffness &ge;60 minutes, palmar telangiectasia, Raynaud phenomenon, unexplained rash on the extensor surfaces of digits (Gottron sign).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Serologic features</strong> &ndash; Antinuclear antibody (ANA) &ge;1:320 (diffuse, speckled, homogeneous), ANA any titer with a nucleolar pattern, ANA any titer with a centromere pattern; rheumatoid factor &ge;2 times upper limit of normal; antibodies to cyclic citrullinated peptide (anti-CCP), double-stranded (ds) DNA, Ro (SS-A), La (SS-B), ribonucleoprotein (RNP), Smith, topoisomerase (Scl-70), tRNA synthetase (eg, Jo-1, PL-7, PL-12), PM-Scl, or melanoma differentiation-associated gene 5 (MDA-5).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Morphologic features</strong> &ndash; Morphologic features include the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>High resolution computed tomography (HRCT) appearance suggestive of NSIP or other idiopathic interstitial pneumonia (IIP) (<a href=\"image.htm?imageKey=PULM%2F60070\" class=\"graphic graphic_table graphicRef60070 \">table 4</a>). (See <a href=\"#H4070053323\" class=\"local\">'Chest imaging studies'</a> below.) </p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Histopathologic patterns or features of NSIP or another IIP. (See <a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">&quot;Idiopathic interstitial pneumonias: Clinical manifestations and pathology&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Multicompartment involvement such as unexplained pleural thickening or effusion, unexplained pericardial thickening or effusion, unexplained intrinsic airways disease (by pulmonary function testing, HRCT, or pathology), and unexplained pulmonary vasculopathy.</p><p/><p>Several studies have noted that a high portion of patients with NSIP have underlying features suggestive of CTD [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/18,20-22\" class=\"abstract_t\">18,20-22</a>]. In a case-control study of 28 patients with NSIP who had no clear underlying disease, 88 percent had laboratory or clinical features of undifferentiated connective tissue disease (autoimmune features) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/18\" class=\"abstract_t\">18</a>]. These features included arthralgias, gastroesophageal reflux disease (GERD), Raynaud's, sicca symptoms, and dysphagia, in addition to positive serologic studies (eg, rheumatoid factor, ANA, or antibodies to SSA, SSB, RNP, Jo-1, Scl-70). A larger study with prospectively collected data is needed to better define the relationship between &quot;idiopathic&quot; and &quot;connective tissue disease-related&quot; NSIP. (See <a href=\"topic.htm?path=undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes\" class=\"medical medical_review\">&quot;Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2503604539\"><span class=\"h2\">Hypersensitivity pneumonitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In some patients with hypersensitivity pneumonitis (also called extrinsic allergic alveolitis), surgical lung biopsy lacks the characteristic poorly formed granulomata and multinucleated giant cells and has an appearance more typical of NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/23\" class=\"abstract_t\">23</a>]. In patients with chronic bird fancier's lung, 13 of 26 had NSIP; most had some multinucleated giant cells, but only one-fourth had granulomas [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/24\" class=\"abstract_t\">24</a>]. (See <a href=\"topic.htm?path=classification-and-clinical-manifestations-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis\" class=\"medical medical_review\">&quot;Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3012476285\"><span class=\"h2\">Drug-associated NSIP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many drugs, including but not limited to <a href=\"topic.htm?path=flecainide-drug-information\" class=\"drug drug_general\">flecainide</a>, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, <a href=\"topic.htm?path=carmustine-drug-information\" class=\"drug drug_general\">carmustine</a>, <a href=\"topic.htm?path=nitrofurantoin-drug-information\" class=\"drug drug_general\">nitrofurantoin</a>, statins, and <a href=\"topic.htm?path=chlorambucil-drug-information\" class=\"drug drug_general\">chlorambucil</a> have been associated with an NSIP pattern [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/25-31\" class=\"abstract_t\">25-31</a>].</p><p class=\"headingAnchor\" id=\"H500393872\"><span class=\"h2\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP has also been associated with immunoglobulin G4 (IgG4)-related systemic disease [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/32,33\" class=\"abstract_t\">32,33</a>], familial interstitial pneumonia [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/34,35\" class=\"abstract_t\">34,35</a>], and graft versus host disease (GVHD) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/36\" class=\"abstract_t\">36</a>]. Cigarette smoking may also be a factor [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/37-39\" class=\"abstract_t\">37-39</a>].</p><p class=\"headingAnchor\" id=\"H2750300270\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The understanding of the pathogenesis of idiopathic NSIP and other idiopathic interstitial pneumonias (IIPs) is evolving. A potential relationship between NSIP and usual interstitial pneumonia (UIP) is suggested by the commonality of associated diseases, exposures, and genetic mutations, in addition to the observation that individual patients can harbor histopathologic lesions of both UIP and NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/40,41\" class=\"abstract_t\">40,41</a>]. The exact nature of this association is not known. </p><p>Potential contributors to the development and perpetuation of NSIP include epithelial injury and disregulated repair, involvement of the immune system (based on autoimmune features of idiopathic NSIP and the presence of lymphocytes in alveolar septae and bronchoalveolar lavage), and abnormal <span class=\"nowrap\">fibroblast/myofibroblast</span> function leading to excess deposition of collagen. Some of these processes are discussed in the context of <span class=\"nowrap\">UIP/idiopathic</span> pulmonary fibrosis (IPF). (See <a href=\"topic.htm?path=pathogenesis-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">&quot;Pathogenesis of idiopathic pulmonary fibrosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2603523961\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP that is not clearly associated with an underlying cause typically occurs in middle-aged women (67 percent) who are never smokers (69 percent) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/42\" class=\"abstract_t\">42</a>]; NSIP associated with connective tissue disease (CTD) has an equal distribution between men and women. As noted above, some patients with NSIP have idiopathic disease, while others have a predisposing underlying disease or exposure. In a given patient, the clinical features can be limited to those attributable to NSIP or may reflect extrapulmonary manifestations of the associated process. As an example, a known CTD may be present, or features suggestive but not diagnostic of CTD may be present. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>History</strong> &ndash; The most common symptoms of NSIP are dyspnea and cough that have developed subacutely over weeks to months [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/7,8,43\" class=\"abstract_t\">7,8,43</a>]. About one-third of patients have fever or flu-like symptoms. Depending on whether an underlying CTD is present, patients may also report dry mouth or eyes, joint pain or swelling, muscle tenderness or weakness, Raynaud phenomenon, rash or other skin changes, or neurologic symptoms.</p><p/><p class=\"bulletIndent1\">Occasional patients with apparent idiopathic NSIP may develop CTD after the diagnosis of NSIP. In a series of 35 patients initially diagnosed with idiopathic NSIP, 17 percent were subsequently diagnosed with dermatomyositis, Sj&ouml;gren syndrome, or rheumatoid arthritis [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/44\" class=\"abstract_t\">44</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Physical examination</strong> &ndash; The majority of patients have bibasilar crackles, but only 10 to 35 percent have clubbing [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/45\" class=\"abstract_t\">45</a>]. Careful attention should be paid to identifying stigmata of rheumatic disease. Nail bed capillaroscopy may be helpful if systemic sclerosis is suspected.</p><p/><p class=\"headingAnchor\" id=\"H149258156\"><span class=\"h1\">EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NSIP is typically suspected in patients with subacute onset of dyspnea and cough and radiographic evidence of interstitial lung disease. The assessment of patients with suspected NSIP requires a synthesis of clinical, laboratory, pulmonary function, radiographic, and (sometimes) histopathologic data [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/42,46\" class=\"abstract_t\">42,46</a>]. An important component of the evaluation is determining whether the patient has any predisposing conditions or exposures [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/47,48\" class=\"abstract_t\">47,48</a>]. (See <a href=\"#H376211228\" class=\"local\">'Definition and causes'</a> above and <a href=\"topic.htm?path=approach-to-the-adult-with-interstitial-lung-disease-clinical-evaluation\" class=\"medical medical_review\">&quot;Approach to the adult with interstitial lung disease: Clinical evaluation&quot;</a> and <a href=\"topic.htm?path=approach-to-the-adult-with-interstitial-lung-disease-diagnostic-testing\" class=\"medical medical_review\">&quot;Approach to the adult with interstitial lung disease: Diagnostic testing&quot;</a> and <a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">&quot;Idiopathic interstitial pneumonias: Clinical manifestations and pathology&quot;</a>.)</p><p>As cigarette smoking is associated with a number of idiopathic interstitial pneumonias (IIPs), patients who smoke should be advised to stop smoking even prior to making a diagnosis.</p><p class=\"headingAnchor\" id=\"H3681214493\"><span class=\"h2\">Clinical review</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Given the broad differential diagnosis of interstitial lung disease, a detailed history is important to narrow the possibilities. Patients should be asked about exposure to airborne organic antigens (eg, barns, birds, hot tubs, humidifiers, mold, <span class=\"nowrap\">plastic/epoxy</span> manufacture) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/49\" class=\"abstract_t\">49</a>]. A complete list of current and recent medications should be reviewed for agents associated with NSIP; patients should be asked about any history of radiation therapy; and risk factors for HIV infection should be assessed. (See <a href=\"topic.htm?path=approach-to-the-adult-with-interstitial-lung-disease-clinical-evaluation#H4\" class=\"medical medical_review\">&quot;Approach to the adult with interstitial lung disease: Clinical evaluation&quot;, section on 'History'</a> and <a href=\"#H3012476285\" class=\"local\">'Drug-associated NSIP'</a> above.)</p><p>As with any patient being evaluated for interstitial lung disease, nonpulmonary symptoms and signs should be assessed, as described in the table (<a href=\"image.htm?imageKey=PULM%2F73094\" class=\"graphic graphic_table graphicRef73094 \">table 5</a>) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/48\" class=\"abstract_t\">48</a>].</p><p class=\"headingAnchor\" id=\"H704214432\"><span class=\"h2\">Laboratory tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>No laboratory tests are specific for NSIP. However, in the evaluation of patients with dyspnea, cough, and pulmonary radiographic opacities, the usual laboratory tests include a complete blood count and differential, blood urea nitrogen, creatinine, hepatic function tests, brain natriuretic peptide, and urinalysis (<a href=\"image.htm?imageKey=PULM%2F105280\" class=\"graphic graphic_table graphicRef105280 \">table 6</a>). </p><p>For patients without a known CTD, we typically obtain an antinuclear antibody and rheumatoid factor early in the course of the evaluation of ILD. If a systemic rheumatic disease is suspected on the basis of extrathoracic symptoms or signs, we also obtain serologic testing appropriate to those findings (<a href=\"image.htm?imageKey=PULM%2F105280\" class=\"graphic graphic_table graphicRef105280 \">table 6</a>) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/18,50,51\" class=\"abstract_t\">18,50,51</a>]. A broader panel of serologic tests is obtained, as needed, based on results of initial testing and after a diagnosis of NSIP has been made.</p><p>The utility of screening panels for hypersensitivity pneumonitis (HP) is unclear due to problems with specificity. We typically reserve serologic testing for HP for patients with a historical risk factor (eg, occupational or environmental exposures). (See <a href=\"topic.htm?path=diagnosis-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis#H6\" class=\"medical medical_review\">&quot;Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)&quot;, section on 'Serum precipitins'</a>.)</p><p>Testing for HIV infection should be performed unless it can be excluded on the basis of clinical history [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/48\" class=\"abstract_t\">48</a>]. (See <a href=\"topic.htm?path=screening-and-diagnostic-testing-for-hiv-infection\" class=\"medical medical_review\">&quot;Screening and diagnostic testing for HIV infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4041760834\"><span class=\"h2\">Pulmonary function tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulmonary function tests (PFTs) are obtained in most ambulatory adults with dyspnea and cough to determine whether the symptoms are associated with an obstructive or restrictive impairment and whether a gas transfer defect is present. Generally, testing includes spirometry, lung volumes, diffusing capacity for carbon monoxide (DLCO), and a six-minute walk test with assessment of oxygen saturation. While pulmonary function testing is not essential for making the diagnosis of NSIP, monitoring forced vital capacity (FVC) and DLCO is helpful for assessing baseline respiratory impairment, disease progression, response to therapy, and prognosis [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/52\" class=\"abstract_t\">52</a>].</p><p>In patients with NSIP, PFTs typically demonstrate a restrictive ventilatory defect (decreased FVC and total lung capacity [TLC]) and impaired gas transfer manifested by a decrease in DLCO <span class=\"nowrap\">and/or</span> desaturation during ambulatory oximetry [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/49\" class=\"abstract_t\">49</a>]. Mild resting hypoxemia may be present at diagnosis [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/48\" class=\"abstract_t\">48</a>]. (See <a href=\"topic.htm?path=overview-of-pulmonary-function-testing-in-adults\" class=\"medical medical_review\">&quot;Overview of pulmonary function testing in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4070053323\"><span class=\"h2\">Chest imaging studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A chest radiograph is obtained in virtually all adults with persistent symptoms of dyspnea and cough, particularly in the presence of fever. High resolution computed tomography (HRCT) scans should be obtained in all patients suspected of having NSIP on the basis of an abnormal conventional chest radiograph or impaired gas transfer. In addition to aiding the diagnosis, serial HRCT scans may be useful to assess disease improvement or progression [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/53-58\" class=\"abstract_t\">53-58</a>]. (See <a href=\"topic.htm?path=high-resolution-computed-tomography-of-the-lungs\" class=\"medical medical_review\">&quot;High resolution computed tomography of the lungs&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chest radiograph</strong> &ndash; Chest radiographs of NSIP typically show bilaterally increased markings with a basilar predominance [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/59\" class=\"abstract_t\">59</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>High resolution computed tomography</strong> &ndash; HRCT scans should be noncontrast with images obtained at full inspiration, unless expiratory views are needed to look for areas of air trapping (eg, in hypersensitivity pneumonitis). Prone views are often obtained in addition to supine to make sure that dependent atelectasis is not mistaken for interstitial disease.</p><p/><p class=\"bulletIndent1\">The most frequent HRCT findings in NSIP are increased reticular markings (87 percent), traction bronchiectasis (82 percent), lobar volume loss (77 percent), and ground glass opacification (GGO, 42 percent), predominantly in the lower lung zones (92 percent) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/42,60\" class=\"abstract_t\">42,60</a>]. Other studies have found GGO in up to 94 percent of NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/61\" class=\"abstract_t\">61</a>]. Bibasilar GGO that spares the subpleural region is the most characteristic HRCT appearance in NSIP, but is not pathognomonic and was only observed in 21 percent of one series [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/61\" class=\"abstract_t\">61</a>]. When present, it is often associated with manifestations of fibrosis such as volume loss, reticular pattern, <span class=\"nowrap\">and/or</span> traction bronchiectasis. </p><p/><p class=\"bulletIndent1\">The HRCT features of idiopathic NSIP compared to CTD-related NSIP are similar [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/6-8,13,23,43,53-57,62-72\" class=\"abstract_t\">6-8,13,23,43,53-57,62-72</a>].</p><p/><p class=\"bulletIndent1\">Honeycomb change is rare with NSIP; a predominance of honeycombing relative to ground glass attenuation suggests UIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/73-75\" class=\"abstract_t\">73-75</a>]. </p><p/><p class=\"bulletIndent1\">Unlike <span class=\"nowrap\">UIP/IPF</span> where HRCT can at times supplant the need for a surgical lung biopsy, the ability of HRCT to make an accurate diagnosis of NSIP is more limited [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/76\" class=\"abstract_t\">76</a>]. This is in part related to variable inter-reader interpretations of HRCT [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/77\" class=\"abstract_t\">77</a>]. Several series have evaluated the ability of HRCT to make a diagnosis of NSIP (as confirmed by surgical lung biopsy). The accuracy ranges from 66 to 68 percent [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/67,75\" class=\"abstract_t\">67,75</a>]. </p><p/><p class=\"headingAnchor\" id=\"H2152164648\"><span class=\"h2\">Bronchoalveolar lavage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bronchoalveolar lavage (BAL) findings in NSIP are nonspecific, and BAL cell counts cannot be utilized to differentiate NSIP from other IIPs [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/78\" class=\"abstract_t\">78</a>]. The main role of BAL in patients with imaging findings suggestive of NSIP is to exclude other causes of diffuse opacities, such as hemorrhage, infection and malignancy. As a result, BAL is not typically used for the evaluation of suspected IIP unless hypersensitivity pneumonitis, malignancy, or opportunistic infection is likely. (See <a href=\"topic.htm?path=role-of-bronchoalveolar-lavage-in-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Role of bronchoalveolar lavage in diagnosis of interstitial lung disease&quot;</a>.)</p><p>In some reports, a higher percentage of lymphocytes was noted in bronchoalveolar lavage (BAL) from patients with NSIP compared with UIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/7,8,43,62\" class=\"abstract_t\">7,8,43,62</a>]; however, this is not always the case [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/63,78\" class=\"abstract_t\">63,78</a>]. In addition, several other ILDs have BAL lymphocytosis, making this a nonspecific finding. (See <a href=\"topic.htm?path=role-of-bronchoalveolar-lavage-in-diagnosis-of-interstitial-lung-disease#H3\" class=\"medical medical_review\">&quot;Role of bronchoalveolar lavage in diagnosis of interstitial lung disease&quot;, section on 'Lymphocytic BAL'</a>.) </p><p class=\"headingAnchor\" id=\"H2580944988\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A definitive diagnosis of NSIP requires histopathologic analysis of a surgical lung biopsy specimen, accompanied by a multidisciplinary assessment when possible [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/48,50\" class=\"abstract_t\">48,50</a>]. However, a surgical lung biopsy is not always needed to guide management. The need for a surgical lung biopsy to confirm the diagnosis of NSIP largely depends on the presence or absence of an underlying process known to be associated with NSIP and the severity of lung disease. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with a known connective tissue disease (CTD) and a clinical course and high resolution computed tomography (HRCT) pattern consistent with NSIP generally do not need a lung biopsy. (See <a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease#H1151100989\" class=\"medical medical_review\">&quot;Role of lung biopsy in the diagnosis of interstitial lung disease&quot;, section on 'Interstitial lung disease associated with systemic rheumatic disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If drug-induced NSIP is suspected (eg, <a href=\"topic.htm?path=nitrofurantoin-drug-information\" class=\"drug drug_general\">nitrofurantoin</a>, <a href=\"topic.htm?path=flecainide-drug-information\" class=\"drug drug_general\">flecainide</a>, <a href=\"topic.htm?path=amiodarone-drug-information\" class=\"drug drug_general\">amiodarone</a>, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, <a href=\"topic.htm?path=carmustine-drug-information\" class=\"drug drug_general\">carmustine</a>, statins), the culprit drug should be discontinued and lung biopsy deferred pending the response to drug discontinuation. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with exposure to agents associated with hypersensitivity pneumonitis should be evaluated with directed serologic tests and a trial of exposure avoidance. Flexible bronchoscopy may be helpful if bronchoalveolar lavage fluid is lymphocytic (&gt;20 percent), particularly if the <span class=\"nowrap\">CD4/CD8</span> lymphocyte ratio is &lt;1. If confident exclusion of HP is not possible noninvasively, a lung biopsy (transbronchial, surgical) is often needed. (See <a href=\"topic.htm?path=diagnosis-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis\" class=\"medical medical_review\">&quot;Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)&quot;</a>.)</p><p/><p>For patients without one of these underlying diseases or exposures, the decision to proceed with surgical lung biopsy depends on the severity of lung disease. Patients with mild respiratory impairment may prefer to wait for evidence of progression prior to lung biopsy. At the other end of the spectrum for patients with severe respiratory impairment, the benefits of a secure diagnosis need to be carefully weighed against the risks of surgical biopsy in the patients with severe respiratory impairment. Multidisciplinary discussion is helpful to optimize diagnostic accuracy and ensure that subtle clinical and morphologic features are considered and inciting drugs and exposures are not overlooked. (See <a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Role of lung biopsy in the diagnosis of interstitial lung disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3340102351\"><span class=\"h2\">Lung biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For the diagnosis of diffuse interstitial lung disease, surgical biopsy via VATS or thoracotomy is the standard; transbronchial cryobiopsy (cryo-TBB) is gaining acceptance, but is not considered to be a replacement for surgical lung biopsy. Transbronchial lung biopsy (TBLB) has a low diagnostic yield in the IIPs and is generally avoided when NSIP is suspected. (See <a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Role of lung biopsy in the diagnosis of interstitial lung disease&quot;</a>.)</p><p>Ideally, when evaluating interstitial lung disease, surgical samples are obtained from more than one lobe and are greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm. (See <a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease#H6\" class=\"medical medical_review\">&quot;Role of lung biopsy in the diagnosis of interstitial lung disease&quot;, section on 'Specimen collection'</a>.)</p><p class=\"headingAnchor\" id=\"H420529916\"><span class=\"h2\">Histopathology and interpretation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathologic examination by an experienced lung pathologist is essential, and most cases require careful clinical and pathological correlation to arrive at the most accurate final diagnosis [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/79-81\" class=\"abstract_t\">79-81</a>]. Although the histopathologic features of NSIP are well defined, the differentiation of NSIP from other IIPs, particularly idiopathic pulmonary fibrosis <span class=\"nowrap\">(IPF)/usual</span> interstitial pneumonia (UIP), is difficult and even expert pathologists may disagree on a particular biopsy [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/82,83\" class=\"abstract_t\">82,83</a>]. (See <a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Role of lung biopsy in the diagnosis of interstitial lung disease&quot;</a> and <a href=\"topic.htm?path=interpretation-of-lung-biopsy-results-in-interstitial-lung-disease\" class=\"medical medical_review\">&quot;Interpretation of lung biopsy results in interstitial lung disease&quot;</a>.)</p><p>The histopathology of NSIP is characterized by diffuse alveolar wall thickening by uniform fibrosis, but with preservation of the alveolar architecture (<a href=\"image.htm?imageKey=PULM%2F81034\" class=\"graphic graphic_table graphicRef81034 \">table 2</a>) [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/1,49\" class=\"abstract_t\">1,49</a>]. Interstitial inflammation is mild to moderate, and the overall pattern suggests temporal homogeneity. </p><p>The histopathologic features do not fit the patterns of other IIPs such as UIP, desquamative interstitial pneumonia, respiratory bronchiolitis interstitial lung disease, cryptogenic organizing pneumonia, acute interstitial pneumonia, or lymphocytic interstitial pneumonia. While a few fibroblast foci may be present in NSIP, dense alveolar septal fibrosis, organizing pneumonia, granulomas, conspicuous infiltration of lymphocytes or eosinophils, and temporal heterogeneity are absent. (See <a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">&quot;Idiopathic interstitial pneumonias: Clinical manifestations and pathology&quot;</a>.)</p><p>Three separate groups within NSIP have been described: Group I has primarily interstitial inflammation (<a href=\"image.htm?imageKey=PULM%2F75438\" class=\"graphic graphic_picture graphicRef75438 \">picture 1</a>), Group II has both inflammation and fibrosis, and Group III has primarily fibrosis (<a href=\"image.htm?imageKey=PULM%2F58583\" class=\"graphic graphic_picture graphicRef58583 \">picture 2</a>). Group III is distinguished from UIP by the absence of fibroblast foci and the presence of temporal homogeneity [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/6\" class=\"abstract_t\">6</a>].</p><p>The classification of NSIP is further complicated by the fact that areas of both NSIP and UIP can be identified in the same patient when biopsies are taken from multiple locations. Studies evaluating patients with multiple lobe biopsies found a pattern of UIP in one lobe and NSIP in another lobe in 13 to 26 percent of patients [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/40,41\" class=\"abstract_t\">40,41</a>]. These mixed <span class=\"nowrap\">NSIP/UIP</span> cases had a similar prognosis to patients with <span class=\"nowrap\">UIP/IPF</span> in all lobes.</p><p class=\"headingAnchor\" id=\"H2272739239\"><span class=\"h2\">Interstitial pneumonia with autoimmune features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Part of the role of interdisciplinary assessment is to determine whether NSIP is associated with an underlying CTD. In this process, some patients will be identified who do not meet criteria for a specific CTD, but have some subtle &quot;autoimmune&quot; features. An international consensus task force has proposed classifying such patients as having &quot;interstitial pneumonia with autoimmune features&quot; [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"#H718396560\" class=\"local\">'Interstitial pneumonia with autoimmune features'</a> above.)</p><p>If not already performed, the serologic testing outlined in the table can help identify patients with IPAF (<a href=\"image.htm?imageKey=PULM%2F114388\" class=\"graphic graphic_table graphicRef114388 \">table 3</a>). (See <a href=\"#H718396560\" class=\"local\">'Interstitial pneumonia with autoimmune features'</a> above.)</p><p class=\"headingAnchor\" id=\"H572240318\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of NSIP includes the other idiopathic interstitial pneumonias (IIPs), other diseases with histopathologic features of NSIP, such as rheumatic diseases (eg, rheumatoid arthritis, systemic sclerosis), chronic hypersensitivity pneumonitis, asbestosis, and certain drug-induced lung diseases.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other idiopathic interstitial pneumonias</strong> &ndash; Usual interstitial <span class=\"nowrap\">pneumonia/idiopathic</span> pulmonary fibrosis <span class=\"nowrap\">(UIP/IPF)</span> is the IIP that has the greatest overlap with NSIP. The imaging findings and histopathology of <span class=\"nowrap\">UIP/IPF</span> and the differentiating features of the various IIPs are discussed separately (<a href=\"image.htm?imageKey=PULM%2F60070\" class=\"graphic graphic_table graphicRef60070 \">table 4</a>). (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-idiopathic-pulmonary-fibrosis#H1658879315\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis&quot;, section on 'Histopathology'</a> and <a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">&quot;Idiopathic interstitial pneumonias: Clinical manifestations and pathology&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hypersensitivity pneumonitis</strong> &ndash; Certain imaging features help to differentiate hypersensitivity pneumonitis (HP) from NSIP. High resolution computed tomography (HRCT) findings of centrilobular nodules, mosaic air-trapping, and upper lung zone distribution suggest HP rather than NSIP [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/1,60\" class=\"abstract_t\">1,60</a>]. On histopathology, bronchiolocentric distribution of mononuclear and giant cell inflammation and poorly formed granulomas suggest HP. (See <a href=\"topic.htm?path=diagnosis-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis\" class=\"medical medical_review\">&quot;Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immunoglobulin G4 (IgG4)-related systemic disease &ndash; </strong>A portion of patients with IgG4-related systemic disease have interstitial lung disease [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/32,33\" class=\"abstract_t\">32,33</a>]. While some features are similar to NSIP, histopathology demonstrates infiltration of the lung interstitium with IgG4-positive plasma cells. (See <a href=\"topic.htm?path=overview-of-igg4-related-disease#H360096128\" class=\"medical medical_review\">&quot;Overview of IgG4-related disease&quot;, section on 'Lung and pleural disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Familial interstitial pneumonia</strong> &ndash; Among patients with familial interstitial pneumonia (FIP), a small portion have HRCT and histopathologic features consistent with NSIP, while the majority have features of <span class=\"nowrap\">UIP/IPF</span> [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/34\" class=\"abstract_t\">34</a>]. In a study of HRCT characteristics of FIP, patients with FIP were more likely to have a diffuse craniocaudal distribution of opacities, whether reticular or mixed reticular-ground glass, while <span class=\"nowrap\">UIP/IPF</span> and NSIP are typically basilar predominant [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/35\" class=\"abstract_t\">35</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hermansky-Pudlak syndrome</strong> &ndash; Hermansky-Pudlak syndrome is a rare genetic defect associated with oculocutaneous albinism, abnormal platelets, and fibrotic interstitial lung disease. While the lung disease is similar to <span class=\"nowrap\">UIP/IPF</span> in most patients, some patients have features more typical of NSIP, such as onset at an earlier age (eg, thirties) reticular and ground glass opacities on HRCT, and on histopathology, temporal homogeneity, sparse mononuclear cell infiltration, and diffuse collagen deposition [<a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/84\" class=\"abstract_t\">84</a>]. Foamy swelling of type II pneumocytes is a clue to the underlying HPS. </p><p/><p class=\"headingAnchor\" id=\"H1594353254\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonspecific interstitial pneumonia (NSIP) is a distinct clinical entity within the idiopathic interstitial pneumonias (IIPs). (See <a href=\"#H574550203\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The histopathologic lesion characteristic of NSIP is thickening of the alveolar septum with varying degrees of inflammatory cell infiltration and fibrosis in a pattern suggesting temporal homogeneity. The fibroblast foci and temporal heterogeneity typical of usual interstitial pneumonia (UIP) are rarely seen. (See <a href=\"#H420529916\" class=\"local\">'Histopathology and interpretation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>NSIP may be idiopathic or may be associated with connective tissue disease (CTD), certain drugs, human immunodeficiency virus infection, and hypersensitivity pneumonitis. (See <a href=\"#H149258156\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disease onset is typically in the fifth or sixth decades of life, with men and women affected equally. Most patients present with the insidious onset of dyspnea and cough. (See <a href=\"#H2603523961\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When NSIP is suspected, the usual laboratory tests include a complete blood count and differential, blood urea nitrogen, creatinine, hepatic function tests, brain natriuretic peptide, and urinalysis (<a href=\"image.htm?imageKey=PULM%2F105280\" class=\"graphic graphic_table graphicRef105280 \">table 6</a>). For patients without a known CTD, we typically obtain an antinuclear antibody and rheumatoid factor early in the course of the evaluation. We obtain additional serologic testing, guided by extrathoracic symptoms or signs and results of initial testing. (See <a href=\"#H704214432\" class=\"local\">'Laboratory tests'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary function testing generally includes spirometry, lung volumes, diffusing capacity for carbon monoxide (DLCO), and a six-minute walk test with oximetry. NSIP is typically associated with a restrictive ventilatory defect (decreased forced vital capacity and total lung capacity) and impaired gas transfer manifested by a decrease in DLCO <span class=\"nowrap\">and/or</span> desaturation during ambulatory oximetry. (See <a href=\"#H4041760834\" class=\"local\">'Pulmonary function tests'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bibasilar diffuse ground glass or reticular opacities are typical findings on chest radiograph. High resolution computed tomography (HRCT) usually shows ground glass and reticular opacities, predominantly in the lower lung zones. Traction bronchiectasis and lobar volume loss may be present, but honeycombing is generally absent. (See <a href=\"#H4070053323\" class=\"local\">'Chest imaging studies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with known underlying connective tissue disease or HIV infection AND HRCT findings consistent with NSIP, histopathologic confirmation of NSIP is generally not necessary. (See <a href=\"#H2580944988\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For most patients without an underlying process known to be associated with NSIP, lung biopsy obtained by thoracoscopy or thoracotomy and multidisciplinary clinicopathologic correlation are needed to confirm a diagnosis of NSIP. (See <a href=\"#H2580944988\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Once the diagnosis of NSIP has been made, every effort should be made to identify any exposure or concomitant systemic disease that is contributory. (See <a href=\"#H420529916\" class=\"local\">'Histopathology and interpretation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of NSIP includes the other IIPs, other diseases with histopathologic features of NSIP, such as rheumatic diseases (eg, rheumatoid arthritis, systemic sclerosis), chronic hypersensitivity pneumonitis, asbestosis, and certain drug-induced lung diseases. (See <a href=\"#H572240318\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/1\" class=\"nounderline abstract_t\">Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188:733.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/2\" class=\"nounderline abstract_t\">Doffman SR, Miller RF. Interstitial lung disease in HIV. Clin Chest Med 2013; 34:293.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/3\" class=\"nounderline abstract_t\">George MP, Singh V, Gladwin MT. Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection. Semin Respir Crit Care Med 2016; 37:289.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/4\" class=\"nounderline abstract_t\">Suffredini AF, Ognibene FP, Lack EE, et al. Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 107:7.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/5\" class=\"nounderline abstract_t\">Narayanswami G, Narasimhan M, Rosen M, et al. Pulmonary complications of HIV disease in the era of highly active antiretroviraltherapy (HAART). Chest 2002; 122:34S.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/6\" class=\"nounderline abstract_t\">Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18:136.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/7\" class=\"nounderline abstract_t\">Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998; 158:1286.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/8\" class=\"nounderline abstract_t\">Fujita J, Yamadori I, Suemitsu I, et al. Clinical features of non-specific interstitial pneumonia. Respir Med 1999; 93:113.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/9\" class=\"nounderline abstract_t\">Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164:1182.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/10\" class=\"nounderline abstract_t\">Miki H, Mio T, Nagai S, et al. Fibroblast contractility: usual interstitial pneumonia and nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2000; 162:2259.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/11\" class=\"nounderline abstract_t\">Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165:1581.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/12\" class=\"nounderline abstract_t\">Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19:121.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/13\" class=\"nounderline abstract_t\">Yamadori I, Fujita J, Bandoh S, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sj&ouml;gren's syndrome. Rheumatol Int 2002; 22:89.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/14\" class=\"nounderline abstract_t\">Yoshinouchi T, Ohtsuki Y, Fujita J, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005; 26:121.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/15\" class=\"nounderline abstract_t\">Xu W, Xiao Y, Liu H, et al. Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med 2014; 14:175.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/16\" class=\"nounderline abstract_t\">Fischer A, Meehan RT, Feghali-Bostwick CA, et al. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest 2006; 130:976.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/17\" class=\"nounderline abstract_t\">Arulkumaran N, Periselneris N, Gaskin G, et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 2011; 50:2035.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/18\" class=\"nounderline abstract_t\">Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007; 176:691.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/19\" class=\"nounderline abstract_t\">Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/20\" class=\"nounderline abstract_t\">Kim HC, Ji W, Kim MY, et al. Interstitial pneumonia related to undifferentiated connective tissue disease: pathologic pattern and prognosis. Chest 2015; 147:165.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/21\" class=\"nounderline abstract_t\">Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012; 39:661.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/22\" class=\"nounderline abstract_t\">Ahmad K, Barba T, Gamondes D, et al. Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients. Respir Med 2017; 123:56.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/23\" class=\"nounderline abstract_t\">Vourlekis JS, Schwarz MI, Cool CD, et al. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 2002; 112:490.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/24\" class=\"nounderline abstract_t\">Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005; 60:665.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/25\" class=\"nounderline abstract_t\">Pesenti S, Lauque D, Daste G, et al. Diffuse infiltrative lung disease associated with flecainide. Report of two cases. Respiration 2002; 69:182.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/26\" class=\"nounderline abstract_t\">Lantuejoul S, Brambilla E, Brambilla C, Devouassoux G. Statin-induced fibrotic nonspecific interstitial pneumonia. Eur Respir J 2002; 19:577.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/27\" class=\"nounderline abstract_t\">Brinker A, Johnston M. Acute pulmonary injury in association with amiodarone. Chest 2004; 125:1591.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/28\" class=\"nounderline abstract_t\">Ridley MG, Wolfe CS, Mathews JA. Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature. Ann Rheum Dis 1988; 47:784.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/29\" class=\"nounderline abstract_t\">Arakawa H, Yamasaki M, Kurihara Y, et al. Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18:231.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/30\" class=\"nounderline abstract_t\">Rossi SE, Erasmus JJ, McAdams HP, et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20:1245.</a></li><li class=\"breakAll\">Pneumotox: The drug-induced respiratory disease website. http://www.pneumotox.com/ (Accessed on June 08, 2017).</li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/32\" class=\"nounderline abstract_t\">Takato H, Yasui M, Ichikawa Y, et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47:291.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/33\" class=\"nounderline abstract_t\">Zhang H, Shi JH, Feng RE, et al. [The clinicopathological analysis of 4 cases of IgG4-related nonspecific interstitial pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2012; 35:747.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/34\" class=\"nounderline abstract_t\">Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172:1146.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/35\" class=\"nounderline abstract_t\">Lee HY, Seo JB, Steele MP, et al. High-resolution CT scan findings in familial interstitial pneumonia do not conform to those of idiopathic interstitial pneumonia. Chest 2012; 142:1577.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/36\" class=\"nounderline abstract_t\">Uhlving HH, Andersen CB, Christensen IJ, et al. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21:531.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/37\" class=\"nounderline abstract_t\">Marten K, Milne D, Antoniou KM, et al. Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol 2009; 19:1679.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/38\" class=\"nounderline abstract_t\">Shinohara T, Kadota N, Hino H, et al. Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation. Respir Med Case Rep 2015; 14:7.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/39\" class=\"nounderline abstract_t\">Sawata T, Bando M, Nakayama M, et al. Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern. Intern Med 2016; 55:2939.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/40\" class=\"nounderline abstract_t\">Monaghan H, Wells AU, Colby TV, et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125:522.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/41\" class=\"nounderline abstract_t\">Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/42\" class=\"nounderline abstract_t\">Travis WD, Hunninghake G, King TE Jr, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177:1338.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/43\" class=\"nounderline abstract_t\">Park CS, Jeon JW, Park SW, et al. Nonspecific interstitial pneumonia/fibrosis: clinical manifestations, histologic and radiologic features. Korean J Intern Med 1996; 11:122.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/44\" class=\"nounderline abstract_t\">Kono M, Nakamura Y, Yoshimura K, et al. Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease. Respir Med 2016; 117:40.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/45\" class=\"nounderline abstract_t\">Flaherty KR, Martinez FJ, Travis W, Lynch JP 3rd. Nonspecific interstitial pneumonia (NSIP). Semin Respir Crit Care Med 2001; 22:423.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/46\" class=\"nounderline abstract_t\">Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170:904.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/47\" class=\"nounderline abstract_t\">Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008; 31:11.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/48\" class=\"nounderline abstract_t\">Belloli EA, Beckford R, Hadley R, Flaherty KR. Idiopathic non-specific interstitial pneumonia. Respirology 2016; 21:259.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/49\" class=\"nounderline abstract_t\">American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165:277.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/50\" class=\"nounderline abstract_t\">Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5:v1.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/51\" class=\"nounderline abstract_t\">Fujita J, Ohtsuki Y, Yoshinouchi T, et al. Idiopathic non-specific interstitial pneumonia: as an &quot;autoimmune interstitial pneumonia&quot;. Respir Med 2005; 99:234.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/52\" class=\"nounderline abstract_t\">Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168:531.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/53\" class=\"nounderline abstract_t\">Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195:645.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/54\" class=\"nounderline abstract_t\">Kim EY, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation. AJR Am J Roentgenol 1999; 173:949.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/55\" class=\"nounderline abstract_t\">Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000; 55:854.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/56\" class=\"nounderline abstract_t\">Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 2003; 123:1096.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/57\" class=\"nounderline abstract_t\">Nishiyama O, Kondoh Y, Taniguchi H, et al. Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J Comput Assist Tomogr 2000; 24:41.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/58\" class=\"nounderline abstract_t\">Akira M, Inoue Y, Arai T, et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66:61.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/59\" class=\"nounderline abstract_t\">Kinder BW. Nonspecific interstitial pneumonia. Clin Chest Med 2012; 33:111.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/60\" class=\"nounderline abstract_t\">Silva CI, M&uuml;ller NL, Lynch DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246:288.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/61\" class=\"nounderline abstract_t\">Park IN, Jegal Y, Kim DS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 2009; 33:68.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/62\" class=\"nounderline abstract_t\">Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12:1010.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/63\" class=\"nounderline abstract_t\">Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160:899.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/64\" class=\"nounderline abstract_t\">Kim TS, Lee KS, Chung MP, et al. Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. AJR Am J Roentgenol 1998; 171:1645.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/65\" class=\"nounderline abstract_t\">Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:199.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/66\" class=\"nounderline abstract_t\">Johkoh T, M&uuml;ller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211:555.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/67\" class=\"nounderline abstract_t\">Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217:701.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/68\" class=\"nounderline abstract_t\">MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221:600.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/69\" class=\"nounderline abstract_t\">Riha RL, Duhig EE, Clarke BE, et al. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J 2002; 19:1114.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/70\" class=\"nounderline abstract_t\">Johkoh T, M&uuml;ller NL, Colby TV, et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225:199.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/71\" class=\"nounderline abstract_t\">Jegal Y, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171:639.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/72\" class=\"nounderline abstract_t\">Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22 Spec No:S151.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/73\" class=\"nounderline abstract_t\">Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19:275.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/74\" class=\"nounderline abstract_t\">Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124:1215.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/75\" class=\"nounderline abstract_t\">Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58:143.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/76\" class=\"nounderline abstract_t\">Silva CI, M&uuml;ller NL, Hansell DM, et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247:251.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/77\" class=\"nounderline abstract_t\">Aziz ZA, Wells AU, Hansell DM, et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59:506.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/78\" class=\"nounderline abstract_t\">Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003; 22:239.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/79\" class=\"nounderline abstract_t\">Jo HE, Glaspole IN, Levin KC, et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 2016; 21:1438.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/80\" class=\"nounderline abstract_t\">Ferri C, Manfredi A, Sebastiani M, et al. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 2016; 15:61.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/81\" class=\"nounderline abstract_t\">Castelino FV, Goldberg H, Dellaripa PF. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology (Oxford) 2011; 50:489.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/82\" class=\"nounderline abstract_t\">Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59:500.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/83\" class=\"nounderline abstract_t\">Lettieri CJ, Veerappan GR, Parker JM, et al. Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. Respir Med 2005; 99:1425.</a></li><li><a href=\"https://www.uptodate.com/contents/causes-clinical-manifestations-evaluation-and-diagnosis-of-nonspecific-interstitial-pneumonia/abstract/84\" class=\"nounderline abstract_t\">Furuhashi K, Enomoto N, Fujisawa T, et al. Hermansky-Pudlak syndrome with nonspecific interstitial pneumonia. Intern Med 2014; 53:449.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 112195 Version 3.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1594353254\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H574550203\" id=\"outline-link-H574550203\">INTRODUCTION</a></li><li><a href=\"#H376211228\" id=\"outline-link-H376211228\">DEFINITION AND CAUSES</a><ul><li><a href=\"#H445277849\" id=\"outline-link-H445277849\">HIV infection</a></li><li><a href=\"#H1892991025\" id=\"outline-link-H1892991025\">Connective tissue disease</a></li><li><a href=\"#H718396560\" id=\"outline-link-H718396560\">Interstitial pneumonia with autoimmune features</a></li><li><a href=\"#H2503604539\" id=\"outline-link-H2503604539\">Hypersensitivity pneumonitis</a></li><li><a href=\"#H3012476285\" id=\"outline-link-H3012476285\">Drug-associated NSIP</a></li><li><a href=\"#H500393872\" id=\"outline-link-H500393872\">Other</a></li></ul></li><li><a href=\"#H2750300270\" id=\"outline-link-H2750300270\">PATHOGENESIS</a></li><li><a href=\"#H2603523961\" id=\"outline-link-H2603523961\">CLINICAL FEATURES</a></li><li><a href=\"#H149258156\" id=\"outline-link-H149258156\">EVALUATION</a><ul><li><a href=\"#H3681214493\" id=\"outline-link-H3681214493\">Clinical review</a></li><li><a href=\"#H704214432\" id=\"outline-link-H704214432\">Laboratory tests</a></li><li><a href=\"#H4041760834\" id=\"outline-link-H4041760834\">Pulmonary function tests</a></li><li><a href=\"#H4070053323\" id=\"outline-link-H4070053323\">Chest imaging studies</a></li><li><a href=\"#H2152164648\" id=\"outline-link-H2152164648\">Bronchoalveolar lavage</a></li></ul></li><li><a href=\"#H2580944988\" id=\"outline-link-H2580944988\">DIAGNOSIS</a><ul><li><a href=\"#H3340102351\" id=\"outline-link-H3340102351\">Lung biopsy</a></li><li><a href=\"#H420529916\" id=\"outline-link-H420529916\">Histopathology and interpretation</a></li><li><a href=\"#H2272739239\" id=\"outline-link-H2272739239\">Interstitial pneumonia with autoimmune features</a></li></ul></li><li><a href=\"#H572240318\" id=\"outline-link-H572240318\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1594353254\" id=\"outline-link-H1594353254\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/112195|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/75438\" class=\"graphic graphic_picture\">- Cellular NSIP histology</a></li><li><a href=\"image.htm?imageKey=PULM/58583\" class=\"graphic graphic_picture\">- Fibrosing NSIP histology</a></li></ul></li><li><div id=\"PULM/112195|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/95445\" class=\"graphic graphic_table\">- Classification of idiopathic interstitial pneumonias</a></li><li><a href=\"image.htm?imageKey=PULM/81034\" class=\"graphic graphic_table\">- Histologic features NSIP</a></li><li><a href=\"image.htm?imageKey=PULM/114388\" class=\"graphic graphic_table\">- Interstitial pneumonia with autoimmune features</a></li><li><a href=\"image.htm?imageKey=PULM/60070\" class=\"graphic graphic_table\">- Radiologic Ddx IIP</a></li><li><a href=\"image.htm?imageKey=PULM/73094\" class=\"graphic graphic_table\">- Extrapulmonary signs in ILD</a></li><li><a href=\"image.htm?imageKey=PULM/105280\" class=\"graphic graphic_table\">- Lab testing in ILD</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-interstitial-pneumonia-hamman-rich-syndrome\" class=\"medical medical_review\">Acute interstitial pneumonia (Hamman-Rich syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-interstitial-lung-disease-clinical-evaluation\" class=\"medical medical_review\">Approach to the adult with interstitial lung disease: Clinical evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-interstitial-lung-disease-diagnostic-testing\" class=\"medical medical_review\">Approach to the adult with interstitial lung disease: Diagnostic testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=classification-and-clinical-manifestations-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis\" class=\"medical medical_review\">Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptogenic-organizing-pneumonia\" class=\"medical medical_review\">Cryptogenic organizing pneumonia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-hypersensitivity-pneumonitis-extrinsic-allergic-alveolitis\" class=\"medical medical_review\">Diagnosis of hypersensitivity pneumonitis (extrinsic allergic alveolitis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=high-resolution-computed-tomography-of-the-lungs\" class=\"medical medical_review\">High resolution computed tomography of the lungs</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=idiopathic-interstitial-pneumonias-clinical-manifestations-and-pathology\" class=\"medical medical_review\">Idiopathic interstitial pneumonias: Clinical manifestations and pathology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interpretation-of-lung-biopsy-results-in-interstitial-lung-disease\" class=\"medical medical_review\">Interpretation of lung biopsy results in interstitial lung disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interstitial-lung-disease-associated-with-sjogren-syndrome-clinical-manifestations-evaluation-and-diagnosis\" class=\"medical medical_review\">Interstitial lung disease associated with Sj&ouml;gren syndrome: Clinical manifestations, evaluation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interstitial-lung-disease-in-dermatomyositis-and-polymyositis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Interstitial lung disease in dermatomyositis and polymyositis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=interstitial-lung-disease-in-rheumatoid-arthritis\" class=\"medical medical_review\">Interstitial lung disease in rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-classification-of-scleroderma-disorders\" class=\"medical medical_review\">Overview and classification of scleroderma disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-igg4-related-disease\" class=\"medical medical_review\">Overview of IgG4-related disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-pulmonary-complications-of-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Overview of pulmonary complications of systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-pulmonary-function-testing-in-adults\" class=\"medical medical_review\">Overview of pulmonary function testing in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">Pathogenesis of idiopathic pulmonary fibrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-bronchiolitis-associated-interstitial-lung-disease\" class=\"medical medical_review\">Respiratory bronchiolitis-associated interstitial lung disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=respiratory-tract-involvement-in-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">Respiratory tract involvement in granulomatosis with polyangiitis and microscopic polyangiitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-bronchoalveolar-lavage-in-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">Role of bronchoalveolar lavage in diagnosis of interstitial lung disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=role-of-lung-biopsy-in-the-diagnosis-of-interstitial-lung-disease\" class=\"medical medical_review\">Role of lung biopsy in the diagnosis of interstitial lung disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-and-diagnostic-testing-for-hiv-infection\" class=\"medical medical_review\">Screening and diagnostic testing for HIV infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-idiopathic-pulmonary-fibrosis\" class=\"medical medical_review\">Treatment of idiopathic pulmonary fibrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes\" class=\"medical medical_review\">Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes</a></li></ul></div></div>","javascript":null}